Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Dasatinib Resensitizes MAPK Inhibitor Efficacy in Standar... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Dasatinib Resensitizes MAPK Inhibitor Efficacy in Standard-of-Care Relapsed Melanomas
0
Authors
Vito Rebecca
18 more
Vito Rebecca
•
Qin Liu
16 more
•
Meenhard Herlyn
Published
January 21, 2023
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Cancer Oncology
Medicine
Paleontology
Internal Medicine
Show all topics
DOI
10.1101/2023.01.20.524923
License
CC-BY-NC-ND
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Cancer Oncology
Medicine
Paleontology
Internal Medicine
Show all topics
DOI
10.1101/2023.01.20.524923
License
CC-BY-NC-ND
Other Formats
PDF
